OpGen.jpg
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections
April 19, 2021 07:30 ET | OpGen, Inc.
Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021 Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse®...
Biogen_Logo_Standard-rgb_R.jpg
Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients
April 19, 2021 07:30 ET | Biogen Inc.
Initial findings from the DEVOTE study suggest no new safety concerns and support continued development of a higher dose of SPINRAZA® (nusinersen)Additional research reinforces the potential of...
fax_logo.jpg
FAX Capital Provides Date for Q1 2021 Results
April 19, 2021 07:30 ET | FAX Capital Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICES TORONTO, April 19, 2021 (GLOBE NEWSWIRE) -- FAX Capital Corp. (TSX: FXC and FXC.WT) (the “Company”) today...
Verde Bio Holdings Logo.jpg
Verde Bio Holdings, Inc. Updates with Letter to Shareholders
April 19, 2021 07:30 ET | Verde Bio Holdings, Inc.
DEAR SHAREHOLDERS: FRISCO, TX, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Verde Bio Holdings, Inc. (OTC: VBHI) To Our Valued Friends and Shareholders:We hope that you and your families...
TBIO.jpg
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
April 19, 2021 07:30 ET | Translate Bio, Inc.
-- Multiple antigen constructs, including the construct used in MRT5500, induced potent neutralizing antibodies against SARS-CoV-2 in preclinical studies in multiple species -- -- Efficacy...
Blucora.jpg
Blucora Board Sends Letter to Stockholders
April 19, 2021 07:30 ET | Blucora, Inc.
Refreshed Board Has Taken Decisive Steps to Drive Long-Term Shareholder Value and Continues to Evaluate Strategic Options Stockholders Urged to Vote “FOR” ALL of Blucora’s Highly Qualified Directors...
salarius-logo-rgb-72dpi.jpg
Salarius Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentations at the 2021 American Society of Clinical Oncology Annual Meeting
April 19, 2021 07:30 ET | Salarius Pharmaceuticals, Inc.
HOUSTON, April 19, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric...
Biosin Logo New.jpg
BioShin Limited Broadens Senior Leadership Team with Veteran Pharma and Biotech Strategy and Business Development Executive
April 19, 2021 07:30 ET | BioShin
SHANGHAI, China, April 19, 2021 (GLOBE NEWSWIRE) -- BioShin Limited, biopharmaceutical company focused on the discovery, development and commercialization of novel, life-improving treatments for...
01A LifeMD Teal Blue.png
LifeMD Announces Expected Record Revenue of $18.2M for Q1’21, Up 323% Vs. Q1’20, Due to Growth in Subscriptions and Patient Acquisition
April 19, 2021 07:30 ET | LifeMD, Inc.
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced expected record revenue of $18.2M for Q1’21....
AuxlyLogo.jpg
Imperial Brands PLC Extends $123 Million Convertible Debenture and Defers Interest
April 19, 2021 07:30 ET | Auxly Cannabis Group Inc.
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated March 23, 2021 to its short form base shelf prospectus dated March 18, 2021. ...